These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17669007

  • 41. Immune modulation by helminthic infections: worms and viral infections.
    Kamal SM, El Sayed Khalifa K.
    Parasite Immunol; 2006 Oct; 28(10):483-96. PubMed ID: 16965284
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [Abstract] [Full Text] [Related]

  • 46. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A, Woltman AM, Janssen HL.
    Best Pract Res Clin Gastroenterol; 2008 Oct; 22(6):1049-61. PubMed ID: 19187866
    [Abstract] [Full Text] [Related]

  • 47. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.
    Vaccine; 2008 Mar 04; 26(10):1375-86. PubMed ID: 18272264
    [Abstract] [Full Text] [Related]

  • 48. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
    Wedemeyer H, Schuller E, Schlaphoff V, Stauber RE, Wiegand J, Schiefke I, Firbas C, Jilma B, Thursz M, Zeuzem S, Hofmann WP, Hinrichsen H, Tauber E, Manns MP, Klade CS.
    Vaccine; 2009 Aug 13; 27(37):5142-51. PubMed ID: 19559112
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    J Med Virol; 2008 Jun 13; 80(6):980-8. PubMed ID: 18428149
    [Abstract] [Full Text] [Related]

  • 51. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM.
    J Gastroenterol Hepatol; 2009 Feb 13; 24(2):238-42. PubMed ID: 19215334
    [Abstract] [Full Text] [Related]

  • 52. Vaccinations in solid-organ transplant patients: what a health professional should know.
    Masters JM, Thomsen AK, Hayney MS.
    J Am Pharm Assoc (2003); 2009 Feb 13; 49(3):458-9. PubMed ID: 19443329
    [No Abstract] [Full Text] [Related]

  • 53. Clinical relevance of age-related immune dysfunction.
    Castle SC.
    Clin Infect Dis; 2000 Aug 13; 31(2):578-85. PubMed ID: 10987724
    [Abstract] [Full Text] [Related]

  • 54. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.
    Bull Cancer; 2008 Nov 13; 95(11):1029-38. PubMed ID: 19036674
    [Abstract] [Full Text] [Related]

  • 55. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS.
    Liver Int; 2008 Feb 13; 28(2):271-7. PubMed ID: 18028320
    [Abstract] [Full Text] [Related]

  • 56. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients.
    Ungulkraiwit P, Jongjirawisan Y, Atamasirikul K, Sungkanuparph S.
    Southeast Asian J Trop Med Public Health; 2007 Jul 13; 38(4):680-5. PubMed ID: 17883006
    [Abstract] [Full Text] [Related]

  • 57. Hepatitis B vaccine-specific CD4(+) T cells can be detected and characterised at the single cell level: limited usefulness of dendritic cells as signal enhancers.
    Litjens NH, Huisman M, Baan CC, van Druningen CJ, Betjes MG.
    J Immunol Methods; 2008 Jan 31; 330(1-2):1-11. PubMed ID: 18061610
    [Abstract] [Full Text] [Related]

  • 58. Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Aycock R.
    Hepatology; 2000 Oct 31; 32(4 Pt 1):873; author reply 874-5. PubMed ID: 11041687
    [No Abstract] [Full Text] [Related]

  • 59. Can hepatitis B vaccination enhance immune response in all patients with chronic liver disease?
    Ozgenç F, Dikici B, Yagci RV.
    Aliment Pharmacol Ther; 2004 Jul 15; 20(2):247. PubMed ID: 15233706
    [No Abstract] [Full Text] [Related]

  • 60. Immune states in long-term space flights.
    Ginsberg HS.
    Life Sci Space Res; 1971 Jul 15; 9():1-9. PubMed ID: 12206176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.